- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,865GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,865GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- October 2024
- 133 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- February 2025
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- January 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 51 Pages
Global
From €5456EUR$5,995USD£4,634GBP
- Report
- December 2024
- 150 Pages
Global
From €3056EUR$3,358USD£2,596GBP
€3595EUR$3,950USD£3,054GBP
- Report
- July 2024
- 154 Pages
Global
From €3288EUR$3,613USD£2,793GBP
€3868EUR$4,250USD£3,285GBP
- Report
- July 2024
- 151 Pages
Global
From €3288EUR$3,613USD£2,793GBP
€3868EUR$4,250USD£3,285GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,049GBP
- Report
- March 2025
- 110 Pages
Global
From €3973EUR$4,365USD£3,374GBP
€4414EUR$4,850USD£3,749GBP
- Report
- December 2024
- 123 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- December 2024
- 1121 Pages
Global
From €9097EUR$9,995USD£7,727GBP
- Report
- January 2024
- 157 Pages
Global
From €4232EUR$4,650USD£3,595GBP
- Report
- December 2021
- 95 Pages
Global
From €4505EUR$4,950USD£3,827GBP

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy.
The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more